Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stomach balloon helps shed pounds in new registry study

NCT ID NCT07062094

Recruiting now Disease control Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 25 times

Summary

This study tracks 200 obese adults in the EU who choose to get the Orbera365 intragastric balloon for weight loss. Researchers will monitor serious side effects and how many people lose at least 10% of their total body weight over up to 12 months. The balloon is placed in the stomach to help control appetite and is removed after treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dorsia Clinic, Madrid Spain

    NOT_YET_RECRUITING

    Madrid, Spain

    Contact

    Contact

  • EndoBes - Centre Medico Teknon

    NOT_YET_RECRUITING

    Barcelona, Spain

    Contact

    Contact

  • Hôpital Avicenne

    NOT_YET_RECRUITING

    Bobigny, France

    Contact

    Contact

  • OB Klinika

    RECRUITING

    Prague, Czechia

    Contact

    Contact

  • UHCW NHS Trust

    NOT_YET_RECRUITING

    Coventry, West Midlands, CV2 2DX, United Kingdom

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.

OBESITY